Skip to main content
. 2023 May 24;2023(5):CD015201. doi: 10.1002/14651858.CD015201

Breland 2021.

Study characteristics
Notes English title
BMI and risk for severe COVID‐19 among Veterans Health Administration patients
Study setting
Start of study recruitment (MM/YYYY): 03/2021
End of study recruitment (MM/YYYY): 05/2021
Study design: Prospective cohort
Study centre(s): Multiple centres/clinics/areas within a country
Number of centres, clinics or areas: NR
Study setting: Outpatient and inpatient
Number of participants recruited: 9347
Sampling method: Consecutive participants
Participants
Female participants (absolute number): 833
Age measure, value: NR
Inclusion criteria: The Veterans Health Administration (VHA) who tested positive for COVID‐19, who had a valid BMI measurement, and who were not VHA employees.
Exclusion criteria: Weight < 75 or ≥ 700 lb and height < 48 or ≥ 84 inches
Smoking frequency: NR
Diabetes frequency: 3560
Hypertension frequency: 5820
Cardiovascular disease frequency: 3003
Asthma frequency: 554
Chronic obstructive pulmonary disease frequency: NR
Other pulmonary disease frequency: 1881
Immunosuppression frequency: 710
Chronic kidney disease frequency: 290
Cancer frequency: NR
Steroid administration frequency: NR
Supplemental oxygen administration frequency: NR
Other treatments (frequency): NR
Prognostic factor(s)
Study’s definition for obesity: NR
The time when obesity has been measured: Before disease or right at presentation
Main variable used for determination of obesity: BMI
Threshold used for definition: NR
Obesity frequency (absolute number): NR
Prognostic factor(s): BMI 23‐30 kg/m2
BMI 30‐39 kg/m2
Outcome(s)
Mortality
ICU admission
Hospitalisation
Outcome (prognostic factor)
BMI 23‐30 kg/m2 (mortality)
Follow‐up
Number of patients followed completely for the outcome: 9347
Number of obese patients followed completely for the outcome: NR
Number of non‐obese patients followed completely for the outcome: NR
Univariable unadjusted analysis for obesity
Effect measure for obesity: NR
Effect measure value (95% CI), P value: NR
Multivariable analysis for obesity
Modelling method: Logistic regression
The set of prognostic factors used for adjustment: Age
Effect measure for obesity: Odds ratio
Effect measure value (95% CI), P value: 0.96 (0.93, 0.98), NR
Outcome (prognostic factor)
BMI 23‐30 kg/m2 (ICU admission)
Follow‐up
Number of patients followed completely for the outcome: 9347
Number of obese patients followed completely for the outcome: NR
Number of non‐obese patients followed completely for the outcome: NR
Univariable unadjusted analysis for obesity
Effect measure for obesity: NR
Effect measure value (95% CI), P value: NR
Multivariable analysis for obesity
Modelling method: Logistic regression
The set of prognostic factors used for adjustment: Age
Effect measure for obesity: Odds ratio
Effect measure value (95% CI), P value: 0.99 (0.97, 1.02), NR
Outcome (prognostic factor)
BMI 23‐30 kg/m2 (hospitalisation)
Follow‐up
Number of patients followed completely for the outcome: 9347
Number of obese patients followed completely for the outcome: NR
Number of non‐obese patients followed completely for the outcome: NR
Univariable unadjusted analysis for obesity
Effect measure for obesity: NR
Effect measure value (95% CI), P value: NR
Multivariable analysis for obesity
Modelling method: Logistic regression
The set of prognostic factors used for adjustment: Age
Effect measure for obesity: Odds ratio
Effect measure value (95% CI), P value: 0.97 (0.95, 0.99), NR
Outcome (prognostic factor)
BMI 30‐39 kg/m2 (mortality)
Follow‐up
Number of patients followed completely for the outcome: 9347
Number of obese patients followed completely for the outcome: NR
Number of non‐obese patients followed completely for the outcome: NR
Univariable unadjusted analysis for obesity
Effect measure for obesity: NR
Effect measure value (95% CI), P value: NR
Multivariable analysis for obesity
Modelling method: Logistic regression
The set of prognostic factors used for adjustment: Age
Effect measure for obesity: Odds ratio
Effect measure value (95% CI), P value: 1.02 (1.02, 1.04), NR
Outcome (prognostic factor)
BMI 30‐39 kg/m2 (ICU admission)
Follow‐up
Number of patients followed completely for the outcome: 9347
Number of obese patients followed completely for the outcome: NR
Number of non‐obese patients followed completely for the outcome: NR
Univariable unadjusted analysis for obesity
Effect measure for obesity: NR
Effect measure value (95% CI), P value: NR
Multivariable analysis for obesity
Modelling method: Logistic regression
The set of prognostic factors used for adjustment: Age
Effect measure for obesity: Odds ratio
Effect measure value (95% CI), P value: 1.01 (1.00, 1.03), NR
Outcome (prognostic factor)
BMI 30‐39 kg/m2 (hospitalisation)
Follow‐up
Number of patients followed completely for the outcome: 9347
Number of obese patients followed completely for the outcome: NR
Number of non‐obese patients followed completely for the outcome: NR
Univariable unadjusted analysis for obesity
Effect measure for obesity: NR
Effect measure value (95% CI), P value: NR
Multivariable analysis for obesity
Modelling method: Logistic regression
The set of prognostic factors used for adjustment: Age
Effect measure for obesity: Odds ratio
Effect measure value (95% CI), P value: 1.02 (1.01, 1.03), NR
 
Item Authors' judgement Support for judgement
Study Participation Yes Appendix 3
Study Attrition
Mortality Unclear Appendix 3
Study Attrition
ICU admission Unclear Appendix 3
Study Attrition
Hospitalisation Unclear Appendix 3
Prognostic Factor Measurement Unclear Appendix 3
Outcome Measurement
Mortality Yes Appendix 3
Outcome Measurement
ICU admission Yes Appendix 3
Outcome Measurement
Hospitalisation Yes Appendix 3
Confounding Bias
Mortality Yes Appendix 3
Confounding Bias
ICU admission Yes Appendix 3
Confounding Bias
Hospitalisation Yes Appendix 3
Statistical Analysis Bias Yes Appendix 3